28-Oct-2026 18:13:52
JAGSNPHARMGeneral news
JAGSONPAL PHARMACEUTICALS Q2 FY27 (STANDALONE) ; NET PROFIT UP 0.13% AT ₹12.59 CR (YOY), DOWN 4.54% (QOQ)
REVENUE UP 9.28% AT ₹81.38 CR (YOY), DOWN 1.04% (QOQ) EBITDA UP 2.02% AT ₹16.77 CR (YOY), DOWN 2.75% (QOQ) MARGINS AT 20.60% VS 22.07% (YOY), 20.97% (QOQ)
JAGSONPAL PHARMACEUTICALS